Answers are grounded in this paper and cite their sources.
Presentes no INSIGHT Strategic Timing of AntiRetroviral Treatment Study Group: Beatriz Grinsztejn; Sandra Wagner Cardoso (Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil).
No takes yet. Share an insight, caveat, or question.
A 2015 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: